Ormat is in a clear intermediate-term downtrend despite a marginally positive 1-year price change of +3.55%, with the current price of $97.34 sitting at just 11.8% of its 52-week range (52-week low of $90.62, 52-week high of $146.39). This positioning near the bottom of the annual range signals that the stock has surrendered virtually all of its prior gains and is testing territory that could represent either a value accumulation zone or a continuation of the bearish trend. The 1-year return of +3.55% masks severe internal deterioration, as the stock peaked at $146.39 in June 2026 and has since fallen roughly 33.5% from that high, with a maximum drawdown of -37.15% confirming the severity of the reversal. The stock is trading just 7.4% above its 52-week low of $90.62, meaning a breakdown below that level would put it at multi-year lows and likely trigger further selling pressure.

Short-term momentum is decisively negative and accelerating to the downside, with a 1-month price change of -11.77% and a 3-month decline of -23.76%, both dramatically worse than the already-weak 6-month return of -8.53% and YTD decline of -14.41%. This pattern of progressively worse returns over shorter time horizons indicates that selling pressure is intensifying rather than stabilizing, with the most recent month representing the steepest decline phase. The stock's relative strength versus SPY is deeply negative across all timeframes — -10.81% over 1 month, -25.76% over 3 months, and -26.11% YTD — confirming that Ormat is not merely declining in absolute terms but is being aggressively sold relative to a market (SPY +15.01% over 1 year) that has been rising. The recent price action from $107.97 on September 8 to $91.20 on September 15 (a -15.5% collapse in five sessions) followed by a modest bounce to $97.34 suggests a potential short-term capitulation, but the bounce remains unconfirmed without volume data.

Key technical levels are well-defined: the 52-week low at $90.62 represents critical support, and the September 15 intraday breach toward $91.20 tested this zone before bouncing, suggesting some buyer interest at these levels. Resistance is layered, with the first meaningful hurdle at the $100 psychological level, followed by the $107-$110 zone (the August consolidation area), and major resistance at the 52-week high of $146.39. The stock's beta of 0.898 indicates it is slightly less volatile than the broader market, which is somewhat unusual for a stock experiencing a -37.15% maximum drawdown and suggests the decline is driven by company-specific factors rather than broad market beta. The short ratio of 7.54 is notably elevated, indicating that short sellers have built a significant position — roughly 7.5 days of average volume would be needed to cover — which could fuel a sharp short squeeze if the stock stabilizes above $90.62 support or if positive catalysts emerge.

Ormat's revenue trajectory remains solidly positive, with Q4 2025 revenue of $276.04 million representing 19.63% year-over-year growth versus Q4 2024's $230.74 million, continuing a multi-quarter expansion pattern from $229.76 million in Q1 2025, $234.02 million in Q2 2025, and $249.73 million in Q3 2025. The sequential progression from Q1 through Q4 2025 shows consistent top-line acceleration, with the Electricity segment generating $186.64 million of the Q4 total, underscoring the company's core power generation business as the primary growth engine. However, the critical tension is that despite this healthy 19.63% revenue growth, trailing EPS has collapsed to just $0.018 per share, suggesting that rising interest expenses, depreciation from heavy capital investment, and other below-the-line costs are consuming nearly all of the incremental revenue. The analyst consensus estimated EPS of $3.95 for the forward year implies a dramatic earnings recovery that will require either significant margin expansion or a substantial reduction in below-the-line drag.

Profitability metrics reveal a company that is technically profitable but operating with thin and volatile margins: Q4 2025 net income was $31.35 million (net margin of 11.36%), down from $40.82 million in Q4 2024 (net margin of 17.69%), despite the 19.63% revenue increase. Gross margin has been compressing, falling from 31.88% in Q4 2024 to 28.56% in Q4 2025, and the quarterly gross margin trend across 2025 (31.74% in Q1, 24.31% in Q2, 25.64% in Q3, 28.56% in Q4) shows significant volatility with no clear upward trajectory. Operating income fell to $54.93 million in Q4 2025 from $49.09 million in Q4 2024, but the operating margin of 19.90% masks the heavy burden of interest expense of $35.02 million per quarter, which consumes approximately 64% of operating income. The company's net margin of 12.52% and operating margin of 18.47% are reasonable for a capital-intensive utility, but the declining trend and the disproportionate impact of financing costs on a leveraged balance sheet are eroding shareholder value.

The balance sheet and cash flow picture presents the most significant fundamental risk: free cash flow TTM is deeply negative at -$284.68 million, driven by massive capital expenditure of $619.78 million in 2025 against operating cash flow of only $105.04 million in Q4 2025. The debt-to-equity ratio of 1.12 and current ratio of 0.81 indicate a leveraged balance sheet with limited short-term liquidity cushion, while the cash flow to debt ratio of just 0.037 highlights the company's dependence on external financing to fund its growth pipeline. ROE of 4.87% and ROA of 2.04% are well below what would typically justify the company's valuation, and the dividend payout ratio of 23.46% with a dividend yield of just 0.43% suggests limited shareholder return capacity. The company's capital expenditure coverage ratio of 0.72 (meaning operating cash flow covers only 72% of capex) and dividend-paid-and-capex coverage ratio of 0.69 confirm that Ormat is funding its growth through debt and equity markets rather than internal cash generation, a model that works only if the invested capital eventually generates sufficient returns.